Annual Operating Profit
-$23.44 M
+$14.00 M+37.38%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual operating income is -$23.44 million, with the most recent change of +$14.00 million (+37.38%) on December 31, 2023.
- During the last 3 years, AVTX annual operating profit has risen by +$23.85 million (+50.43%).
- AVTX annual operating profit is now -268.78% below its all-time high of $13.89 million, reached on December 31, 2017.
Performance
AVTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$12.86 M
-$3.39 M-35.78%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly operating income is -$12.86 million, with the most recent change of -$3.39 million (-35.78%) on September 30, 2024.
- Over the past year, AVTX quarterly operating profit has dropped by -$3.39 million (-35.78%).
- AVTX quarterly operating profit is now -158.67% below its all-time high of $21.92 million, reached on September 30, 2017.
Performance
AVTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$31.31 M
-$9.11 M-41.04%
September 30, 2024
Summary
- As of February 8, 2025, AVTX TTM operating income is -$31.31 million, with the most recent change of -$9.11 million (-41.04%) on September 30, 2024.
- Over the past year, AVTX TTM operating profit has dropped by -$9.11 million (-41.04%).
- AVTX TTM operating profit is now -289.08% below its all-time high of $16.56 million, reached on September 30, 2017.
Performance
AVTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
AVTX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.4% | -35.8% | -41.0% |
| 3 y3 years | +50.4% | -45.2% | +16.4% |
| 5 y5 years | -57.3% | -349.4% | +16.4% |
AVTX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +71.5% | -414.1% | +38.3% | -57.5% | +61.9% |
| 5 y | 5-year | -34.8% | +71.5% | -414.1% | +57.9% | -80.0% | +61.9% |
| alltime | all time | -268.8% | +71.5% | -158.7% | +57.9% | -289.1% | +61.9% |
Avalo Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$12.86 M(+35.8%) | -$31.31 M(+41.0%) |
| Jun 2024 | - | -$9.47 M(+81.1%) | -$22.20 M(+11.7%) |
| Mar 2024 | - | -$5.23 M(+39.4%) | -$19.88 M(-15.2%) |
| Dec 2023 | -$23.44 M(-37.4%) | -$3.75 M(+0.0%) | -$23.44 M(-17.9%) |
| Sep 2023 | - | -$3.75 M(-47.6%) | -$28.55 M(+37.9%) |
| Jun 2023 | - | -$7.15 M(-18.7%) | -$20.70 M(-18.4%) |
| Mar 2023 | - | -$8.79 M(-0.7%) | -$25.38 M(-32.2%) |
| Dec 2022 | -$37.44 M(-54.4%) | -$8.86 M(-316.2%) | -$37.44 M(-19.6%) |
| Sep 2022 | - | $4.09 M(-134.6%) | -$46.55 M(-30.6%) |
| Jun 2022 | - | -$11.83 M(-43.3%) | -$67.11 M(-7.3%) |
| Mar 2022 | - | -$20.85 M(+16.1%) | -$72.41 M(-11.8%) |
| Dec 2021 | -$82.13 M(+73.7%) | -$17.96 M(+9.1%) | -$82.14 M(+2.0%) |
| Sep 2021 | - | -$16.46 M(-3.9%) | -$80.51 M(+4.1%) |
| Jun 2021 | - | -$17.13 M(-44.0%) | -$77.33 M(+7.4%) |
| Mar 2021 | - | -$30.58 M(+87.2%) | -$72.01 M(+52.3%) |
| Dec 2020 | -$47.29 M(+171.9%) | -$16.34 M(+23.1%) | -$47.30 M(+28.9%) |
| Sep 2020 | - | -$13.28 M(+12.4%) | -$36.68 M(+39.7%) |
| Jun 2020 | - | -$11.81 M(+101.5%) | -$26.26 M(+43.7%) |
| Mar 2020 | - | -$5.86 M(+2.5%) | -$18.27 M(+5.1%) |
| Dec 2019 | -$17.39 M | -$5.72 M(+100.0%) | -$17.39 M(+27.0%) |
| Sep 2019 | - | -$2.86 M(-25.2%) | -$13.70 M(-15.3%) |
| Jun 2019 | - | -$3.83 M(-23.2%) | -$16.18 M(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$4.98 M(+145.6%) | -$16.40 M(+10.0%) |
| Dec 2018 | -$14.90 M(-207.3%) | -$2.03 M(-62.0%) | -$14.90 M(-13.5%) |
| Sep 2018 | - | -$5.34 M(+32.4%) | -$17.23 M(-271.7%) |
| Jun 2018 | - | -$4.04 M(+15.6%) | $10.03 M(-18.4%) |
| Mar 2018 | - | -$3.49 M(-19.9%) | $12.30 M(-11.5%) |
| Dec 2017 | $13.89 M(-186.4%) | -$4.36 M(-119.9%) | $13.89 M(-16.1%) |
| Sep 2017 | - | $21.92 M(-1335.0%) | $16.56 M(-246.2%) |
| Jun 2017 | - | -$1.77 M(-6.5%) | -$11.32 M(-13.1%) |
| Mar 2017 | - | -$1.90 M(+12.6%) | -$13.04 M(-18.9%) |
| Dec 2016 | -$16.08 M(+46.1%) | -$1.69 M(-71.7%) | -$16.08 M(-11.0%) |
| Sep 2016 | - | -$5.96 M(+71.0%) | -$18.07 M(+28.5%) |
| Jun 2016 | - | -$3.49 M(-29.4%) | -$14.06 M(+4.4%) |
| Mar 2016 | - | -$4.94 M(+34.5%) | -$13.47 M(+22.3%) |
| Dec 2015 | -$11.01 M(-35.7%) | -$3.68 M(+87.6%) | -$11.01 M(-1.4%) |
| Sep 2015 | - | -$1.96 M(-32.2%) | -$11.17 M(-26.6%) |
| Jun 2015 | - | -$2.89 M(+16.4%) | -$15.21 M(-4.8%) |
| Mar 2015 | - | -$2.48 M(-35.2%) | -$15.97 M(-6.7%) |
| Dec 2014 | -$17.12 M(+32.3%) | -$3.83 M(-36.1%) | -$17.12 M(+28.9%) |
| Sep 2014 | - | -$6.00 M(+64.1%) | -$13.28 M(+82.3%) |
| Jun 2014 | - | -$3.66 M(+0.7%) | -$7.28 M(+100.7%) |
| Mar 2014 | - | -$3.63 M | -$3.63 M |
| Dec 2013 | -$12.93 M | - | - |
FAQ
- What is Avalo Therapeutics annual operating income?
- What is the all time high annual operating profit for Avalo Therapeutics?
- What is Avalo Therapeutics annual operating profit year-on-year change?
- What is Avalo Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly operating profit year-on-year change?
- What is Avalo Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Avalo Therapeutics?
- What is Avalo Therapeutics TTM operating profit year-on-year change?
What is Avalo Therapeutics annual operating income?
The current annual operating profit of AVTX is -$23.44 M
What is the all time high annual operating profit for Avalo Therapeutics?
Avalo Therapeutics all-time high annual operating income is $13.89 M
What is Avalo Therapeutics annual operating profit year-on-year change?
Over the past year, AVTX annual operating income has changed by +$14.00 M (+37.38%)
What is Avalo Therapeutics quarterly operating income?
The current quarterly operating profit of AVTX is -$12.86 M
What is the all time high quarterly operating profit for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly operating income is $21.92 M
What is Avalo Therapeutics quarterly operating profit year-on-year change?
Over the past year, AVTX quarterly operating income has changed by -$3.39 M (-35.78%)
What is Avalo Therapeutics TTM operating income?
The current TTM operating profit of AVTX is -$31.31 M
What is the all time high TTM operating profit for Avalo Therapeutics?
Avalo Therapeutics all-time high TTM operating income is $16.56 M
What is Avalo Therapeutics TTM operating profit year-on-year change?
Over the past year, AVTX TTM operating income has changed by -$9.11 M (-41.04%)